IRIS
ARMENI, PATRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.452
NA - Nord America 5.769
AS - Asia 3.119
SA - Sud America 350
AF - Africa 96
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 11
Totale 18.814
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.500
IT - Italia 3.274
RU - Federazione Russa 1.914
FI - Finlandia 1.023
CN - Cina 975
GB - Regno Unito 852
SG - Singapore 809
IE - Irlanda 719
UA - Ucraina 349
VN - Vietnam 341
DE - Germania 340
FR - Francia 289
BR - Brasile 284
HK - Hong Kong 222
CA - Canada 204
SE - Svezia 173
TR - Turchia 161
IN - India 138
NL - Olanda 137
KR - Corea 126
CZ - Repubblica Ceca 61
PL - Polonia 55
BG - Bulgaria 50
ZA - Sudafrica 50
ES - Italia 48
ID - Indonesia 48
IL - Israele 45
BE - Belgio 43
MX - Messico 43
IQ - Iraq 32
BD - Bangladesh 29
JP - Giappone 29
AT - Austria 28
AR - Argentina 26
CH - Svizzera 22
PK - Pakistan 21
AE - Emirati Arabi Uniti 16
IR - Iran 16
RO - Romania 14
AU - Australia 12
DK - Danimarca 12
MA - Marocco 11
PH - Filippine 11
UZ - Uzbekistan 11
CL - Cile 10
CO - Colombia 10
EC - Ecuador 9
MY - Malesia 9
PT - Portogallo 9
TH - Thailandia 9
EU - Europa 8
GR - Grecia 8
JO - Giordania 8
TW - Taiwan 8
SA - Arabia Saudita 7
AZ - Azerbaigian 6
GE - Georgia 6
KE - Kenya 6
LV - Lettonia 6
PA - Panama 6
AM - Armenia 5
EG - Egitto 5
LT - Lituania 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
CR - Costa Rica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
SI - Slovenia 4
DZ - Algeria 3
HN - Honduras 3
HU - Ungheria 3
NO - Norvegia 3
PE - Perù 3
PS - Palestinian Territory 3
SN - Senegal 3
VE - Venezuela 3
AL - Albania 2
BO - Bolivia 2
BY - Bielorussia 2
BZ - Belize 2
CG - Congo 2
EE - Estonia 2
JM - Giamaica 2
LB - Libano 2
LK - Sri Lanka 2
NG - Nigeria 2
OM - Oman 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
UG - Uganda 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BT - Bhutan 1
Totale 18.793
Salva come PNG Salva come JPEG
Città #
Helsinki 957
Ashburn 782
Dublin 717
Milan 711
San Jose 579
Southend 532
Chandler 484
Singapore 432
Dallas 363
Moscow 356
Hefei 353
Rome 282
Jacksonville 276
Ann Arbor 234
Beijing 220
Hong Kong 217
The Dalles 156
New York 150
Toronto 148
Los Angeles 134
Dearborn 128
Seoul 125
Houston 106
Dong Ket 104
Edison 93
Ho Chi Minh City 88
Wilmington 80
Boston 77
Lauterbourg 75
Modena 70
Council Bluffs 66
Boardman 64
Lawrence 64
Naples 60
Munich 58
Bologna 56
Izmir 56
Bari 49
Hanoi 47
Johannesburg 46
Frankfurt am Main 43
Jakarta 41
Redwood City 41
São Paulo 41
Warsaw 41
Tel Aviv 40
Brussels 39
Florence 39
Redmond 39
Turin 39
Buffalo 36
Seattle 36
Orem 35
Mountain View 34
Woodbridge 33
Assago 32
Chennai 32
Genoa 32
Catania 31
Amsterdam 30
Casorate Primo 30
London 30
Brooklyn 27
Tokyo 27
Montreal 26
Falkenstein 23
Santa Clara 21
Lappeenranta 19
Brno 18
Cagliari 18
Chicago 18
Duncan 18
Kunming 18
Mexico City 18
Nanjing 18
Palermo 18
Atlanta 16
Denver 16
Poplar 16
Brescia 15
Busto Arsizio 15
Paris 15
Pescara 15
Stockholm 15
Washington 15
Parma 14
Phoenix 14
Baghdad 13
Palombara Sabina 13
Torino 13
Bonndorf 12
Kocaeli 12
Pisa 12
Verona 12
Vienna 12
Ankara 11
Boydton 11
Monza 11
Rio de Janeiro 11
Ancona 10
Totale 10.995
Salva come PNG Salva come JPEG
Nome #
Digitalizzazione nelle tecnologie per la salute: impatto sui livelli di governo del SSN 699
The cost of patients with chronic kidney failure before dialysis: results from the IRIDE observational study 444
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci 429
Politiche del farmaco ed impatto sulla spesa: gli effetti di quindici anni di decentramento nel SSN, con un focus sull’adozione di forme alternative di distribuzione dei farmaci 413
Dinamiche economiche e performance del settore dei dispositivi medici in Italia 377
La spesa sanitaria: composizione ed evoluzione 364
I dispositivi medici in Italia: un settore, tanti mercati 336
Report n. 42 OSFAR (Osservatorio Farmaci) 318
PDTA per la chirurgia bariatrica: l'esperienza di 6 centri italiani 318
De innovatione: the concept of innovation for medical technologies and its implications for healthcare policy-making 312
La copertura vaccinale nelle regioni italiane. Un’analisi dell’eterogeneità 310
La rendicontazione e la remunerazione dei farmaci. Finalità, struttura e gestione del File F in nove Regioni italiane 296
Cost-effectiveness and net monetary benefit of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the Italian National Health Service 295
Il governo dell'assistenza farmaceutica in Italia: possibili traiettorie di cambiamento 294
Cost-minimization analysis to support the HTA of Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis of osteoporosis 281
L'acquisto di farmaci in Italia: l'effetto di approcci selettivi 277
Il confronto dei sistemi sanitari in una prospettiva internazionale 276
Market access management by pharmaceutical companies in a complex environment: the Italian case study 271
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies 268
Cost-utility analysis of esketamine for patients with treatment resistant depression in Italy 262
The future of Funds for Innovative Medicines: results from a Delphi Study 261
A value-based revolution in health care: perspectives, challenges, and emerging approaches to defining and measuring the value of health care technologies 259
Il governo regionale dell'assistenza farmaceutica e il suo impatto sulla spesa 255
Real-world cost effectiveness of MitraClip combined with medical therapy versus medical therapy alone in patients with moderate or severe mitral regurgitation 254
Comparative effectiveness of Mitraclip plus medical therapy versus medical therapy alone in high-risk surgical patients: a comprehensive review 250
Diffusion without evidence: a study on high-risk medical devices 249
PHP3 the simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study 244
Programma Nazionale di HTA per dispositivi medici: prove tecniche di implementazione 241
L'adozione dell'innovazione tecnologica da parte degli ospedali italiani: un'analisi dei fattori endogeni 235
La spesa sanitaria: composizione ed evoluzione 233
Digital Twins in healthcare: is it the beginning of a new era of evidence-based medicine? A critical review 232
Il confronto dei sistemi sanitari in una prospettiva internazionale 230
Il confronto dei sistemi sanitari in una prospettiva internazionale 230
Programmi di early access dei farmaci e managed entry agreement in Italia: i risultati di un Focus Group (programmi di early access e managed entry agreement) 229
Collecting physicians' preferences on medical devices: are we doing it right? Evidence from Italian orthopedists using 2 different stated preference methods 227
Cost-benefit analysis in health care: the case of bariatric surgery compared with diet 227
La spesa sanitaria: composizione ed evoluzione 224
I settori contigui alla sanità: struttura e performance delle imprese farmaceutiche, di dispositivi medici e delle farmacie in Italia 222
The impact of HTA and procurement practices on the selection and prices of medical devices 220
La spesa sanitaria: composizione ed evoluzione 219
Cost-effectiveness and net monetary benefit of Olaparib maintenance therapy versus no maintenance therapy after first-line platinum-based chemotherapy in newly diagnosed advanced BRCA1/2-mutated ovarian cancer in the Italian National Health Service 216
A meta-analysis of MitraClip combined with medical therapy versus medical therapy alone for treatment of mitral regurgitation in heart failure patients 212
Implementation of value-based pricing for medicines 210
The invisible costs of obstructive sleep apnea (OSA): systematic review and cost-of-illness analysis 201
Il confronto dei sistemi sanitari in una prospettiva internazionale 198
L'attività sperimentale sui dispositivi medici 197
Il confronto dei sistemi sanitari in una prospettiva internazionale 195
The impact of generic reference pricing in Italy, a decade on 189
Politiche del farmaco: approfondimento sul Value Framework per i farmaci 187
When peers count: the effects on integrated type II diabetes care of communication within general practitioner-only subgroups in interprofessional primary care teams 186
La spesa sanitaria: composizione ed evoluzione 186
The impact of generic reference pricing in Italy, a decade on 185
Mobile health divide between clinicians and patients in cancer care: results from a cross-sectional international survey 178
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case 176
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 175
Economic impact of a more extensive use of FENO testing on the Italian population with asthma 172
Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention 172
The social burden and quality of life of patients with haemophilia in Italy 171
Cost-effectiveness analysis of HRD testing for previously treated patients with advanced ovarian cancer in Italy 166
The value of hearing aids for the Italian NHS: a cost-utility analysis 164
La spesa sanitaria: composizione ed evoluzione 163
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 161
The simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study 160
La spesa sanitaria: composizione ed evoluzione 160
Multi-professional primary care units: what affects the clinical performance of Italian general practitioners? 159
Social/economic costs and quality of life in patients with haemophilia in Europe 159
What type of clinical evidence is needed to assess medical devices? 156
Il settore dei dispositivi medici in Italia. L’impatto delle politiche pubbliche sulle performance delle imprese 155
The simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study 154
The simultaneous effects of pharmaceutical policies from payers’ and patients’ perspectives: Italy as a case study 145
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe 141
Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe 135
Social economic costs, health-related quality of life and disability in patients with Cri Du Chat syndrome 135
L’evoluzione del finanziamento dei farmaci in Italia 129
Elicitation of societal preferences for chronic lymphocytic leukemia’s treatments: a discrete choice experiment 125
Economic evaluation of two therapeutic sequences in the first-line treatment of moderate to severe active ulcerative rectocolitis in Italy 125
Exploring the potential of digital therapeutics: an assessment of progress and promise 124
Variations in non-prescription drug consumption and expenditure: determinants and policy implications 124
La spesa sanitaria: composizione ed evoluzione 119
La spesa sanitaria: composizione ed evoluzione 115
La spesa sanitaria: composizione ed evoluzione 114
La spesa sanitaria: composizione ed evoluzione 104
Percutaneous mitral valve repair vs. stand-alone medical therapy in patients with functional mitral regurgitation and heart failure 104
Use of resource modeling to quantify the organizational impact of subcutaneous formulations for the treatment of oncologic patients: the case of daratumumab in multiple myeloma 93
Reflections on the importance of cost of illness analysis in rare diseases: a proposal 90
Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries 89
The role of health systems in shaping vaccine decisions: Insights from Italy, Mexico, the United Kingdom, and the United States 73
Optimizing treatment sequencing in multiple myeloma: a novel model to predict survival outcomes 71
Individual and team performanc: issues around the role of attributes and relationships among peers 69
The economic burden of anesthetic-related adverse events: a systematic review and empirical analysis 40
The relationship between trust and compliance in the Italian NHS: Results of the People's Voice Survey 39
Promoting healthy aging in a digital world: leveraging technology for enhanced elderly care and wellbeing 23
Implementing the EU HTA regulation and joint clinical assessment: a multi-stakeholder perspective from Italy 3
Totale 19.073
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.785
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021399 0 0 0 0 0 0 0 0 0 103 108 188
2021/2022935 68 180 36 41 66 12 31 174 41 47 105 134
2022/20232.347 119 127 58 176 153 189 63 101 977 94 165 125
2023/20241.807 104 97 123 89 167 177 105 279 99 136 211 220
2024/20252.490 138 36 170 123 209 157 162 165 571 286 303 170
2025/20267.780 559 647 292 573 605 336 906 837 2.269 756 0 0
Totale 19.073